Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of CES1 Genotype on Methylphenidate Metabolism
NCT02147535Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Mar 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Bispebjerg and Frederiksberg Hospital. Started Mar 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02147535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147535.